Found: 65
Select item for more details and to access through your institution.
A first-in-human phase I study of TAS0728, an oral covalent binding inhibitor of HER2, in patients with advanced solid tumors with HER2 or HER3 aberrations.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 5, p. 1324, doi. 10.1007/s10637-021-01104-7
- By:
- Publication type:
- Article
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1096, doi. 10.1007/s10637-019-00857-6
- By:
- Publication type:
- Article
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1).
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1117, doi. 10.1007/s10637-019-00856-7
- By:
- Publication type:
- Article
Immunotherapy for bladder cancer: rediscovering an old friend.
- Published in:
- BJU International, 2016, v. 117, n. 5, p. 721, doi. 10.1111/bju.13330
- By:
- Publication type:
- Article
Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-40061-y
- By:
- Publication type:
- Article
Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 1, p. 24, doi. 10.3816/CCC.2011.n.003
- By:
- Publication type:
- Article
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11539-1
- By:
- Publication type:
- Article
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 11, p. e2341165, doi. 10.1001/jamanetworkopen.2023.41165
- By:
- Publication type:
- Article
Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Combination Molecularly Targeted Drug Therapy in Metastatic Melanoma: Progress to Date.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
- Published in:
- British Journal of Cancer, 2024, v. 130, n. 7, p. 1131, doi. 10.1038/s41416-023-02436-2
- By:
- Publication type:
- Article
HIF2α, Hepcidin and their crosstalk as tumour-promoting signalling.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 2, p. 222, doi. 10.1038/s41416-023-02266-2
- By:
- Publication type:
- Article
A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer.
- Published in:
- British Journal of Cancer, 2023, v. 129, n. 1, p. 38, doi. 10.1038/s41416-023-02279-x
- By:
- Publication type:
- Article
Erratum to: Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
Development and Evaluation of a New Technological Way of Engaging Patients and Enhancing Understanding of Drug Tolerability in Early Clinical Development: PROACT.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 167, n. 3, p. 671, doi. 10.1007/s10549-017-4537-5
- By:
- Publication type:
- Article
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
- Published in:
- Gastric Cancer, 2021, v. 24, n. 4, p. 970, doi. 10.1007/s10120-021-01156-x
- By:
- Publication type:
- Article
Health-related quality of life associated with trifluridine/tipiracil in heavily pretreated metastatic gastric cancer: results from TAGS.
- Published in:
- Gastric Cancer, 2020, v. 23, n. 4, p. 689, doi. 10.1007/s10120-020-01053-9
- By:
- Publication type:
- Article
Enumeration and Molecular Characterisation of Circulating Tumour Cells in Endometrial Cancer.
- Published in:
- Oncology, 2016, v. 91, n. 1, p. 48, doi. 10.1159/000445999
- By:
- Publication type:
- Article
Patients' Perceptions of Research Biopsies in Phase I Oncology Trials.
- Published in:
- Oncology, 2015, v. 88, n. 2, p. 95, doi. 10.1159/000368161
- By:
- Publication type:
- Article
Clinical Benefit of New Targeted Agents in Phase I Trials in Patients with Advanced Colorectal Cancer.
- Published in:
- Oncology, 2009, v. 76, n. 3, p. 151, doi. 10.1159/000195884
- By:
- Publication type:
- Article
Signal pathways and precision therapy of small-cell lung cancer.
- Published in:
- Signal Transduction & Targeted Therapy, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41392-022-01013-y
- By:
- Publication type:
- Article
KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Pharmacokinetic Interaction Between the MEK1/MEK2 Inhibitor Trametinib and Oral Contraceptives Containing Norethindrone and Ethinyl Estradiol in Female Patients With Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2022, v. 11, n. 5, p. 585, doi. 10.1002/cpdd.1052
- By:
- Publication type:
- Article
Concordance of Blood-Based and Normal Tissue-Based Dihydropyrimidine Dehydrogenase (DPYD) Genotyping.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Phase I, First‐in‐Human, Dose‐Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Vorolanib in Patients with Advanced Solid Tumors.
- Published in:
- Oncologist, 2019, v. 24, n. 4, p. 455, doi. 10.1634/theoncologist.2018-0740
- By:
- Publication type:
- Article
Ramucirumab Plus Pembrolizumab in Patients with Previously Treated Advanced or Metastatic Biliary Tract Cancer: Nonrandomized, Open‐Label, Phase I Trial (JVDF).
- Published in:
- Oncologist, 2018, v. 23, n. 12, p. 1407, doi. 10.1634/theoncologist.2018-0044
- By:
- Publication type:
- Article
Mammographic Breast Density and Urbanization: Interactions with BMI, Environmental, Lifestyle, and Other Patient Factors.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 6, p. 418, doi. 10.3390/diagnostics10060418
- By:
- Publication type:
- Article
Patient-reported outcomes and inflammatory biomarkers in patients with locally advanced/metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose-escalation study 1108.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 3, p. e35, doi. 10.1111/bjh.15879
- By:
- Publication type:
- Article
Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 53, doi. 10.4137/CMO.S5855
- By:
- Publication type:
- Article
Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities.
- Published in:
- Clinical Medicine Insights: Oncology, 2012, n. 6, p. 53, doi. 10.4137/CMO.S5855
- By:
- Publication type:
- Article
The potential for BRAF V600 inhibitors in advanced cutaneous melanoma: rationale and latest evidence.
- Published in:
- Therapeutic Advances in Medical Oncology, 2012, v. 4, n. 2, p. 61, doi. 10.1177/1758834011432949
- By:
- Publication type:
- Article
Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 4, p. 832, doi. 10.1002/cncr.25636
- By:
- Publication type:
- Article
Gastric cancer in the era of molecularly targeted agents: current drug development strategies.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 7, p. 855, doi. 10.1007/s00432-009-0583-7
- By:
- Publication type:
- Article
Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 13, p. 1, doi. 10.1002/cam4.7385
- By:
- Publication type:
- Article
Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade.
- Published in:
- BioMed Research International, 2017, v. 2017, p. 1, doi. 10.1155/2017/1506824
- By:
- Publication type:
- Article
Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI.H) metastatic endometrial cancer.
- Published in:
- Experimental Hematology & Oncology, 2017, v. 6, p. 1, doi. 10.1186/s40164-016-0061-2
- By:
- Publication type:
- Article
Perceptions and Referral Trends into Phase I Oncology Trials: Results of a Clinical Survey.
- Published in:
- Journal of Oncology, 2011, p. 1, doi. 10.1155/2011/861401
- By:
- Publication type:
- Article
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 5, p. 1, doi. 10.1007/s00262-024-03654-0
- By:
- Publication type:
- Article
Effect of multiple‐dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 12, p. 2877, doi. 10.1111/bcp.13753
- By:
- Publication type:
- Article
Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients with <italic>BRAF</italic> V600–mutant tumours.
- Published in:
- British Journal of Clinical Pharmacology, 2018, v. 84, n. 4, p. 764, doi. 10.1111/bcp.13488
- By:
- Publication type:
- Article
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1465, doi. 10.3390/cancers16081465
- By:
- Publication type:
- Article
Selective RET Inhibitors (SRIs) in Cancer: A Journey from Multi-Kinase Inhibitors to the Next Generation of SRIs.
- Published in:
- Cancers, 2024, v. 16, n. 1, p. 31, doi. 10.3390/cancers16010031
- By:
- Publication type:
- Article
Untailored vs. Gender- and Body-Mass-Index-Tailored Skeletal Muscle Mass Index (SMI) to Assess Sarcopenia in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC).
- Published in:
- Cancers, 2023, v. 15, n. 19, p. 4716, doi. 10.3390/cancers15194716
- By:
- Publication type:
- Article
Irinotecan- vs. Oxaliplatin-Based Doublets in KRAS G12C -Mutated Metastatic Colorectal Cancer—A Multicentre Propensity-Score-Matched Retrospective Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 3064, doi. 10.3390/cancers15113064
- By:
- Publication type:
- Article
Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2978, doi. 10.3390/cancers15112978
- By:
- Publication type:
- Article
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation.
- Published in:
- Cancers, 2022, v. 14, n. 11, p. 2594, doi. 10.3390/cancers14112594
- By:
- Publication type:
- Article
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF Trial.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2985, doi. 10.3390/cancers12102985
- By:
- Publication type:
- Article